Peptech launches dog contraceptive

By Renate Krelle
Thursday, 09 December, 2004

Peptech Animal Health, a wholly owned subsidiary of Sydney-based Peptech (ASX:PTD) has begun to market its slow-release canine contraceptive, Suprelorin, to Australian veterinarians.

The Suprelorin implant is is inserted under the skin between the dog's shoulders . It contains an active ingredient, deslorelin, which causes temporary sterility and suppresses sexual behaviour by inactivating the pituitary-gland receptors for the master signalling molecule, gonadoptrophin-releasing hormone (GnRH). This reduces testosterone levels to zero.

"Castration is widely recommended in Australia and New Zealand, for good health and behavioural reasons," said Peptech Animal Health managing director, Dr Tim Trigg.

"Suprelorin provides the advantages of castration, without resorting to surgery."

Peptech Animal Health recently received an Australian Research Committee (ARC) linkage grant to investigate the use of Suprelorin in controlling large marsupial populations, including koala and kangaroo.

Related News

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd